Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples